 Lexicon Pharmaceuticals LXRX stock is on the rise Thursday after announcing an update from the FDA for its drug sotagliflozin. The post LXRX Stock Alert: Why Lexicon Pharmaceuticals Is Up 100 Today appeared first on InvestorPlace. 